Lurasidone vs. Other Antipsychotics as Augmentation Strategies for Clozapine in Treatment-resistant Schizophrenia: An Observational Multicenter Prospective Study
Although further studies are needed to confirm our findings, lurasidone's favorable side-effect profile should be considered.
Authors
- G Carnevale (ORCID: https://orcid.org/0000-0001-5895-3531)
- Natascia Brondino (ORCID: https://orcid.org/0000-0002-3128-1592)
- F. Mazzoni (ORCID: https://orcid.org/0009-0009-6684-7689)
- Tiziano Prodi (ORCID: https://orcid.org/0009-0001-8528-0480)
- Beatrice Benatti (ORCID: https://orcid.org/0000-0003-0539-7150)
- Bernardo Maria Dell’Osso (ORCID: https://orcid.org/0000-0001-9370-5365)
- Alessandro Grecchi (ORCID: https://orcid.org/0000-0002-3821-2100)
- Miriam Olivola (ORCID: https://orcid.org/0000-0003-0914-0539)
- Margherita Oresti
Institutions
- AOL (United States) (US)
- University of Milan (IT)
- University of Pavia (IT)
- Luigi Sacco Hospital (IT)
- Ospedale San Paolo (IT)
- Ospedale San Carlo (IT)
- Ospedale San Paolo (IT)
- Centro Diagnostico Italiano (IT)
- ASST Fatebenefratelli Sacco (IT)
- Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo
- Stanford University (US)
Publication Details
- Journal
- Current Neuropharmacology
- Published
- 2025-10-08
- DOI
- https://doi.org/10.2174/011570159x399781250910115949
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00